Dr. Zeidi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6700 Steger Dr
Cincinnati, OH 45236- Is this information wrong?
Summary
- I am a Board-certified Pathologist with subspeciality in Dermatopathology.
Education & Training
- Tehran University of Medical Sciences School of MedicineClass of 2004, Board Certified in Anatomic and Clinical Pathology (AP/CP)
Certifications & Licensure
- IL State Medical License 2024 - 2026
- OH State Medical License 2024 - 2026
- MN State Medical License 2024 - 2025
- KY State Medical License 2024 - 2025
- WV State Medical License 2024 - 2025
- PA State Medical License 2023 - 2024
- NY State Medical License 2022 - 2024
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Awards, Honors, & Recognition
- Resident Physician of The Year Department of Pathology “In Recognition of Your Outstanding Dedication, Service and Professional Excellence” NYC Health and Hospitals- Kings County Hospital Center, Brooklyn, NY, 2022
- Certificate of Courage “In recognition of the outstanding service, sacrifice, valor in unprecedented time of pandemic.” SUNY Downstate Health Sciences University, Brooklyn, NY, 2020
- Certificate of Recognition "In Recognition of Outstanding Work and Dedication to The Autoimmune Skin Diseases Unit" University of Pennsylvania, Department of Dermatology, Philadelphia, PA, 2019
Publications & Presentations
PubMed
- 17 citationsHEPATITIS B VIRAL DNA AMONG HBS ANTIGEN NEGATIVE HEALTHY BLOOD DONORSMaryam Vaezjalali, Shabnam Rashidpour, Hanieh Rezaee, Bashir Hajibeigi, Majid Zeidi
Hepatitis Monthly. 2013-03-17 - 11 citationsMyeloid Dendritic Cells Are Major Producers of IFN-β in Dermatomyositis and May Contribute to Hydroxychloroquine Refractoriness.Kristen L. Chen, Jay Patel, Majid Zeidi, Maria Wysocka, Muhammad M. Bashir
The Journal of Investigative Dermatology. 2021-08-01 - 15 citationsSafety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial.Victoria P Werth, Emily Hejazi, Sandra M Pena, Jessica Haber, Majid Zeidi
The Journal of Investigative Dermatology. 2022-10-01
Professional Memberships
- Member
- Member
- College of American Pathologists - CAPMember
External Links
- linkedin https://www.linkedin.com/in/majid-zeidi-md-b2729651/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: